| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |